COMMUNIQUÉS West-GlobeNewswire

HEXO reaches construction and licensing milestones for its massive 1 million sq. ft. greenhouse – on time and on budget
27/12/2018
GATINEAU, Quebec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ) has reached a construction and licensing milestone with the first phase of its 1 million sq. ft. greenhouse expansion [...]
HEXO atteint des jalons concernant sa serre d’un million de pieds carrés – construction et octroi de licence – selon les délais et le budget prévus
27/12/2018
GATINEAU, Québec, 27 déc. 2018 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ) a franchi une étape importante touchant la première phase de l’agrandissement d’un million de pieds carrés de sa [...]
Transactions in relation to share buyback program
27/12/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Organic electronics: Bio-on presents Eloxel, to develop the use of bioplastics in the electronics sector. At his side Kartell, strategic partner
27/12/2018
ELOXEL is born ( organic electronics for electronics ) the new company created by Bio-on to exploit the patents destined to revolutionize the world of electronics through the use of bioplastics. The aim is to enable [...]
Financial calendar of JSC Olainfarm for 2019
27/12/2018
JSC Olainfarm informs that in 2019 submission of financial results is scheduled for the following dates: Unaudited consolidated Annual Report for 2018 – on February 28, 2019; Unaudited consolidated interim financial [...]
Rule 2.9 Announcement
27/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 December 2018 [...]
TRACON Pharmaceuticals Presents Positive Top-line Clinical Data from Dose Escalation Portion of Phase 1 Trial of TRC105 and Opdivo® for Treatment of Non-Small Cell Lung Cancer
26/12/2018
SAN DIEGO, Dec. 26, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
IntelGenx Grants Restricted Share Units
26/12/2018
SAINT LAURENT, Quebec, Dec. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors granted Restricted [...]
Sanofi: FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine
26/12/2018
FDA Approves VAXELIS (TM) , Sanofi and MSD's Pediatric Hexavalent Combination Vaccine PARIS and KENILWORTH, N.J. - December 26 , 2018 - The U.S. Food and Drug Administration has approved VAXELIS(TM) (Diphtheria and [...]
Sanofi : La FDA approuve VAXELIS(TM), le vaccin combiné hexavalent pédiatrique de Sanofi et MSD
26/12/2018
La FDA approuve VAXELIS (TM) , le vaccin combiné hexavalent pédiatrique de Sanofi et MSD PARIS et KENILWORTH (New Jersey) - Le 26 décembre 2018 - La Food and Drug Administration (FDA) des États-Unis a approuvé VAXELIS( [...]
Alzamend Neuro™ Completes New Management Team for 2019
26/12/2018
Appoints Financial Executive, Kenneth S. Cragun, as New CFO and Treasurer Tampa, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed top-tier [...]
TRACON Pharmaceuticals Announces Submission of IND Application for TJ4309 (CD73 Antibody TJD5) for Treatment of Advanced Solid Tumors
26/12/2018
SAN DIEGO, Dec. 26, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
26/12/2018
Acer continues progress toward goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and [...]
Hemispherx Biopharma Issues Business Update to Clarify Apple iOS12 Stocks Application ‘No Recent Stories’ Misinformation
26/12/2018
OCALA, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) continues to work with Apple and other affected parties for a solution to correct Apple iOS12 Stocks Application [...]
Delcath Announces Commercial Licensing Agreement for CHEMOSAT®
26/12/2018
7 Year Agreement with medac to Maximize Potential of CHEMOSAT in Europe Upfront and Milestone Payments Provide Additional Resources to Advance Clinical Development in the U.S. NEW YORK, Dec. 26, 2018 (GLOBE NEWSWIRE [...]
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel
26/12/2018
Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, [...]
Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi
26/12/2018
Opiant Intends to Initiate Development Efforts in 2019 SANTA MONICA, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for [...]
Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership
26/12/2018
Partnership Involves Large-Scale Production of CL2A-SN-38, the Drug-Linker Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and DEVENS, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE [...]
Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation
26/12/2018
DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) [...]

Pages